via University of East Anglia
Customised medicines could one day be manufactured to patients’ individual needs, with University of East Anglia (UEA) researchers investigating technology to 3D ‘print’ pills.
The team, including Dr Andy Gleadall and Prof Richard Bibb at Loughborough University, identified a new additive manufacturing method to allow the 3D printing of medicine in highly porous structures, which can be used to regulate the rate of drug release from the medicine to the body when taken orally.
Dr Sheng Qi, a Reader in Pharmaceutics at UEA’s School of Pharmacy, led the research. The project findings, ‘Effects of porosity on drug release kinetics of swellable and erodible porous pharmaceutical solid dosage forms fabricated by hot melt droplet deposition 3D printing’, are published today in the International Journal of Pharmaceutics.
Dr Qi said: “Currently our medicines are manufactured in ‘one-size-fits-all’ fashion.
“Personalised medicine uses new manufacturing technology to produce pills that have the accurate dose and drug combinations tailored to individual patients. This would allow the patients to get maximal drug benefit with minimal side effects.
“Such treatment approaches can particularly benefit elderly patients who often have to take many different types of medicines per day, and patients with complicated conditions such as cancer, mental illness and inflammatory bowel disease.”
The team’s work, Dr Qi said, is building the foundation for the technology needed in future to produce personalised medicine at the point-of-care. She said 3D printing has the unique ability to produce porous pharmaceutical solid dosage forms on-demand.
Pharmaceutical 3D printing research is a new research field that has rapidly developed in the past five years. Most commonly used 3D printing methods require the drug being processed into spaghetti-like filaments prior to 3D printing.
The team investigated a newly developed 3D printing method that can rapidly produce porous pharmaceutical tablets without the use of filaments. The results revealed that by changing the size of the pores, the speed of a drug escaping from the tablet into the body can be regulated.
Further research will be required in order to use the porosity to tailor the dose and dosing frequency (i.e. once daily or twice daily) of medicine to each patient’s needs, and use this principle to build multiple medicines into a single daily poly-pill for patients who are on a complex medicine regiment.
Original Article: PERSONALISED MEDICATIONS POSSIBLE WITH 3D PRINTING
More from: University of East Anglia | Loughborough University
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Customised medicines
- Regenerative medicine accelerator gains new tenant
A downtown Winston-Salem research innovation initiative has gained a new tenant in RTT Medical, the Wake Forest Institute for Regenerative Medicine said Monday.
- Global Stem Cells Group Expands Its Stem Cell Therapy and Regenerative Medicine Centers to Indonesia
(“Meso Numismatics” or the “Company”) (MSSV), a technology company specializing in Biotech and Numismatics, is pleased to announce additional global expansion by opening stem cell therapy and ...
- Compounding Pharmacy Market Analysis 2022: Topical Medications, Oral Medications, Suppositories - Global Forecast to 2029 - ResearchAndMarkets.com
The "Compounding Pharmacy Market Analysis by Product (Topical Medications, Oral Medications, Suppositories), by Therapeutic Area (Hormone Replacement Medications, Pain Medications, Dermatological ...
- Five companies personalizing treatments with 3D printed drugs
Here are five companies that are leveraging 3D printing to produce customizable drugs tailored to a patient’s needs.
- Foot Levelers Celebrates 70th Anniversary of Innovations in Custom Orthotics
Foot Levelers celebrates its 70th anniversary with a look at the company’s impressive achievements and exciting developments for the future.
Go deeper with Google Headlines on:
Customised medicines
Go deeper with Bing News on:
3D printing of medicines
- University of Bremen: 3D technologies for surgical success in medicine
Scientists and developers of the VIVATOP research network have developed 3D technologies that enable novel, fast and precise OP preparation for surgical interventions. The project results also help ...
- FDA’s Regulatory Framework for 3D Printing of Medical Devices at the Point of Care Needs More Clarity
To plan for the surgical separation of conjoined twin girls in 2020, surgeons at the University of Michigan C.S. Mott Children’s Hospital needed realistic, life-size models of their patients’ shared ...
- Five companies personalizing treatments with 3D printed drugs
Here are five companies that are leveraging 3D printing to produce customizable drugs tailored to a patient’s needs.
- Precise Bio Partners with Carl Zeiss Meditec to Develop 4D-Printed Corneal Transplants
Precise Bio's 4D bio-fabrication technology reportedly will offer a complete solution for procedures involving corneal transplants and alleviate the current shortage of donated corneas.
- Cell Therapy Market to Generate $35.95 billion, Regenerative Therapy and 3D Printing to Remain in Limelight
Global cell therapy market was valued at USD 14.86 billion in 2021, and it is expected to reach a value of USD 35.95 billion by 2028, at a CAGR of 13.45% over the forecast period (202-22028).Westford, ...